Advanced Search
Contact | Corporate | Help

A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung Cancer

Sponsors:
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Non-Small Cell Lung Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: RO5490258
  • Drug: bevacizumab [Avastin]
  • Drug: pemetrexed
  • Drug: Placebo
  • Drug: cisplatin/carboplatin
  • Drug: paclitaxel
Enrollment:
260

Additional information about NCT01496742.


SourceSolution © 2008-2012